| Stephen R Woodworth, MD | |
|
2 Ivy Brook Rd, Suite 205, Shelton, CT 06484-6416 | |
| (203) 922-9466 | |
| (203) 922-9477 |
| Full Name | Stephen R Woodworth |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 27 Years |
| Location | 2 Ivy Brook Rd, Shelton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043283302 | NPI | - | NPPES |
| 010044476CT01 | Other | CT | ANTHEM |
| 001444760 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 044476 (Connecticut) | Primary |
| 207UN0901X | Nuclear Medicine - Nuclear Cardiology | 044476 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Griffin Hospital | Derby, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
| The Griffin Hospital | 8921901984 | 30 |
News Archive
CLARIFY, the largest international registry to ever be carried out in stable coronary artery disease (CAD) patients was launched today in 40 countries, including Canada, at the European Society of Cardiology (ESC) Congress.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
A team led by a Heart and Stroke Foundation researcher has uncovered a series of genes linking mental stress, high blood pressure, alcoholism and tobacco addiction.
CSC announced today that the company, in conjunction with the State of North Carolina, successfully implemented phase one of the North Carolina Medicaid Incentive Payment System.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
› Verified 4 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
CLARIFY, the largest international registry to ever be carried out in stable coronary artery disease (CAD) patients was launched today in 40 countries, including Canada, at the European Society of Cardiology (ESC) Congress.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
A team led by a Heart and Stroke Foundation researcher has uncovered a series of genes linking mental stress, high blood pressure, alcoholism and tobacco addiction.
CSC announced today that the company, in conjunction with the State of North Carolina, successfully implemented phase one of the North Carolina Medicaid Incentive Payment System.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
› Verified 4 days ago
| Entity Name | The Griffin Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184639973 PECOS PAC ID: 8921901984 Enrollment ID: O20040128000937 |
News Archive
CLARIFY, the largest international registry to ever be carried out in stable coronary artery disease (CAD) patients was launched today in 40 countries, including Canada, at the European Society of Cardiology (ESC) Congress.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
A team led by a Heart and Stroke Foundation researcher has uncovered a series of genes linking mental stress, high blood pressure, alcoholism and tobacco addiction.
CSC announced today that the company, in conjunction with the State of North Carolina, successfully implemented phase one of the North Carolina Medicaid Incentive Payment System.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen R Woodworth, MD 2 Ivy Brook Rd, Suite 205, Shelton, CT 06484-6416 Ph: (203) 922-9466 | Stephen R Woodworth, MD 2 Ivy Brook Rd, Suite 205, Shelton, CT 06484-6416 Ph: (203) 922-9466 |
News Archive
CLARIFY, the largest international registry to ever be carried out in stable coronary artery disease (CAD) patients was launched today in 40 countries, including Canada, at the European Society of Cardiology (ESC) Congress.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
A team led by a Heart and Stroke Foundation researcher has uncovered a series of genes linking mental stress, high blood pressure, alcoholism and tobacco addiction.
CSC announced today that the company, in conjunction with the State of North Carolina, successfully implemented phase one of the North Carolina Medicaid Incentive Payment System.
Nearly 60,000 Americans suffer from myasthenia gravis (MG), a non-inherited autoimmune form of muscle weakness. The disease has no cure, and the primary treatments are nonspecific immunosuppressants and inhibitors of the enzyme cholinesterase.
› Verified 4 days ago
Lenore M Snowden Opalak, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4 Corporate Dr, Suite 394, Shelton, CT 06484 Phone: 203-225-0375 Fax: 203-225-0376 | |
Dr. Piotr Waldemar Baginski, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr, Suite 283, Shelton, CT 06484 Phone: 203-944-9775 Fax: 203-944-9964 | |
Dr. Murugesapillai Koneswaran, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 21 Huntington Plaza, Shelton, CT 06484 Phone: 203-929-6358 Fax: 203-929-3826 | |
Dr. Lavanya Bellumkonda, MBBS Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4 Corporate Dr Ste 100, Shelton, CT 06484 Phone: 203-929-9799 | |
Joseph Thomas Coyne, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Rd, Ste 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 | |
John Farens, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 |